// App-Quantinova.ai

20 : Anti-Angiotensin II Type 1-Receptor Antibodies (AT1R-Ab) Induce a Specific Phenotype of Rejection Distinct from HLA Antibody-Mediated Rejection

Researchers

Presenter

  • C. Lefaucheur

Principal Investigators

  • D. Viglietti

  • O. Aubert

  • A. Philippe

  • P. Halloran

  • A. Loupy

  • D. Dragun

Medical Centers

  • Paris Translational Research Center for organ Transplantation, Paris, France

  • Medical Faculty of the Charité Berlin, Berlin, Germany

  • Alberta Transplant Applied Genomics Centre, Edmonton, Canada

Locations

  • France

  • Germany

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Angiotensin II

Outcome

  • N/A

Study Design

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved